Animal Generic Drug User Fee Act; Public Meeting; Request for Comments
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public meeting entitled "Animal Generic Drug User Fee Act." The purpose of the public meeting is to invite public comment on the Animal Generic Drug User Fee Act (AGDUFA) program and suggestions regarding the features FDA shou
| Agency | Health and Human Services Department, Food and Drug Administration |
|---|---|
| Document type | Notice |
| Published | 2026-04-17 |
| Summary | The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public meeting entitled "Animal Generic Drug User Fee Act." The purpose of the public meeting is to invite public comment on the Animal Generic Drug User Fee Act (AGDUFA) program and suggestions regarding the features FDA should consider for the next reauthorization of the AGDUFA program. The meeting will be open to the public. |
| Document number | 2026-07497 |
| Official record | https://www.federalregister.gov/documents/2026/04/17/2026-07497/animal-generic-drug-user-fee-act-public-meeting-request-for-comments |